Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.09
0.03 (1.46%)
At close: Aug 21, 2025, 11:27 AM

Daré Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
-17.7K 25.91K 9.78K 1.88M 2.84M 2.82M 2.81M 10B 10B 10.01B 10.01B 10M 10M n/a n/a n/a n/a n/a
Cost of Revenue
9.74K 34.74K 42.42K 52.4K 51.91K 36.53K 28.86K 23.59K 17.37K 13.07K 18.3K 89.98K 69.21K 70.5K 71.68K 20.28K 63.02K 77.24K
Gross Profit
-14.25M -14.23M -14.26M 1.83M 2.79M 2.78M 2.78M 10B 10B 10.01B 10.01B 9.91M 9.93M -70.5K -71.68K -20.28K -63.02K -77.24K
Operating Income
-18.48M -22.01M -23.42M -23.2M -26.92M -28.55M -30.94M -42M -40.74M -31.37M -31.39M -24.7M -30.23M -39.77M -39.07M -37.97M -32.88M -30.84M
Interest Income
69.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-18.6M -1.68M -4.05M -3.6M -7.2M -28.87M -30.16M -41.05M -39.77M -30.59M -30.95M -24.55M -30.19M -39.77M -38.7M -37.59M -32.51M -30.47M
Net Income
-18.6M -1.68M -4.05M -3.6M -7.2M -28.87M -30.16M -41.05M -39.77M -30.59M -30.95M -24.55M -30.19M -39.77M -38.7M -37.59M -32.51M -30.47M
Selling & General & Admin
8.72M 8.82M 9.17M 10.13M 10.78M 11.23M 11.91M 12.18M 12.14M 12.01M 11.24M 10.42M 9.98M 8.98M 8.35M 7.73M 6.87M 6.63M
Research & Development
9.69M 13.17M 14.21M 14.7M 18.71M 19.85M 21.54M 30.72M 28.5M 29.26M 30.04M 24.18M 30.15M 30.69M 30.62M 30.14M 25.91M 24.12M
Other Expenses
18.32K 18.32K 17.77K 113.67K 138.9K 138.9K 138.9K 125K 100K 129.68K 131.46K 32.29K 33.8K 4.3K 2.52K 746.00 -1.75K -305
Operating Expenses
18.44M 22.01M 23.39M 25.01M 29.71M 31.32M 33.71M 43M 40.74M 41.37M 41.39M 34.7M 40.23M 39.77M 39.07M 37.97M 32.88M 30.84M
Interest Expense
268.53K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
409K 409K 365.55K 341.55K 272.55K 417.55K 600K 540K 531K 536K 566K 576K 594K 595K 561K 627K 569K 494K
Cost & Expenses
18.46M 22.04M 23.43M 25.06M 29.73M 31.34M 33.72M 43M 40.74M 41.37M 41.39M 34.7M 40.23M 39.77M 39.07M 37.97M 32.88M 30.84M
Income Tax Expense
n/a n/a n/a -33.83K -43.09K -43.09K -43.09K -9.26K n/a n/a -1.78K -71.14K -47.05K -47.05K -45.27K 24.09K n/a n/a
Shares Outstanding (Basic)
8.87M 8.76M 8.5M 8.53M 8.41M 8.38M 7.3M 7.59M 7.2M 7.13M 6.8M 7.07M 7.11M 7M 4.34M 4.27M 4.2M 3.71M
Shares Outstanding (Diluted)
8.87M 8.76M 8.5M 8.53M 8.48M 8.38M 7.3M 7.59M 7.2M 7.13M 6.8M 7.07M 7.11M 7M 4.34M 4.27M 4.2M 3.71M
EPS (Basic)
-2.15 -0.17 -0.48 -0.52 -1.06 -3.81 -4.13 -5.78 -5.67 -4.39 -3.36 -1.15 -0.35 -0.59 -0.65 -0.79 -0.85 -0.94
EPS (Diluted)
-2.15 -0.18 -0.49 -0.53 -1.07 -3.81 -4.13 -5.78 -5.67 -4.39 -3.36 -1.15 -3.14 -3.38 -3.44 -3.58 -0.85 -0.94
EBITDA
-17.84M -21.82M -23.41M -23.19M -26.9M -28.54M -30.9M -41.96M -40.71M -31.34M -31.36M -24.68M -30.2M -39.75M -39.04M -37.94M -32.85M -30.8M
EBIT
-18.48M -22.01M -23.45M -23.12M -26.84M -28.46M -30.83M -42M -40.74M -31.37M -31.39M -24.7M -30.23M -39.77M -39.07M -37.97M -32.88M -30.84M
Depreciation & Amortization
634.29K 189.66K 42.33K 45.94K 45.45K 39.63K 38.36K 39.01K 32.78K 28.48K 24.2K 89.98K 93.29K 94.59K 95.77K 26.16K 32.32K 37.69K